Sphera Funds Management Ltd. Pro Qr Therapeutics N.V. Transaction History

Sphera Funds Management Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$4.5 - $6.53 $1.56 Million - $2.26 Million	-346,148 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.25 - $9.9 $2.41 Million - $4.54 Million	-458,852 Reduced 57.0%	346,148 $1.9 Million
Q4 2019 Feb 13, 2020	SELL	$5.84 - $10.51 $642,400 - $1.16 Million	-110,000 Reduced 12.02%	805,000 $7.98 Million
Q3 2019 Nov 14, 2019	BUY	$5.76 - $9.44 $2.56 Million - $4.2 Million	445,000 Added 94.68%	915,000 $5.27 Million
Q2 2019 Aug 14, 2019	BUY	$9.1 - $15.55 $2.55 Million - $4.35 Million	280,000 Added 147.37%	470,000 $0
Q1 2019 May 15, 2019	SELL	$12.5 - $18.48 $1.88 Million - $2.77 Million	-150,000 Reduced 44.12%	190,000 $2.64 Million
Q4 2018 Feb 14, 2019	SELL	$15.25 - $22.4 $895,922 - $1.32 Million	-58,749 Reduced 14.73%	340,000 $5.37 Million
Q3 2018 Nov 14, 2018	SELL	$6.45 - $21.6 $612,750 - $2.05 Million	-95,000 Reduced 19.24%	398,749 $7.72 Million
Q2 2018 Aug 13, 2018	SELL	$2.95 - $7.45 $486,015 - $1.23 Million	-164,751 Reduced 25.02%	493,749 $3.6 Million
Q1 2018 May 10, 2018	BUY	$2.9 - $3.5 $372,650 - $449,750	128,500 Added 24.25%	658,500 $2.03 Million
Q3 2017 Nov 09, 2017	BUY	$4.35 - $6.45 $2.31 Million - $3.42 Million	530,000	530,000 $2.57 Million

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $188M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.